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Summary
Cellular reprogramming from somatic cells to induced
pluripotent stem cells (iPSCs) can be achieved through
forced expression of the transcription factors Oct4, Klf4,
Sox2, and c-Myc (OKSM) [1–4]. These factors, in com-
bination with environmental cues, induce a stable intrinsic
pluripotency network that confers indefinite self-renewal
capacity on iPSCs. In addition to Oct4 and Sox2, the
homeodomain-containing transcription factor Nanog is an
integral part of the pluripotency network [5–11]. Although
Nanog expression is not required for the maintenance of
pluripotent stem cells, it has been reported to be essential
for the establishment of both embryonic stem cells (ESCs)
from blastocysts and iPSCs from somatic cells [10, 12].
Here we revisit the role of Nanog in direct reprogramming.
Surprisingly, we find that Nanog is dispensable for
iPSC formation under optimized culture conditions. We
further document that Nanog-deficient iPSCs are trans-
criptionally highly similar to wild-type iPSCs and support
the generation of teratomas and chimeric mice. Lastly,
we provide evidence that the presence of ascorbic acid
in the culture media is critical for overcoming the previ-
ously observed reprogramming block of Nanog knockout
cells.
Results
Endogenous Nanog Is Not Required for Induced
Pluripotency
In order to test whether Nanog is required for direct reprog-
ramming, we derived Nanog–/– mouse embryonic fibroblasts
(MEFs) from chimeric embryos [13] since complete deletion
of Nanog is embryonic lethal [10, 12]. Nanog–/– MEFs could
be distinguished from host blastocyst-derived wild-type cells*Correspondence: khochedlinger@helix.mgh.harvard.edubased on constitutive CAG-green fluorescent protein (GFP)
expression as well as Nanog promoter-driven neomycin resis-
tance. Fluorescence-activated cell sorting (FACS) of GFP+
cells yielded a starting population of 89% purity. The re-
maining GFP2 cells were expected to be wild-type MEFs or
Nanog2/2 MEFs that had silenced the GFP transgene. The
GFP-enriched MEFs were transduced with lentiviral vectors
expressing OKSM from a doxycycline (dox)-inducible poly-
cistronic construct (also referred to as STEMCCA) and rtTA
(reverse tetracycline transactivator) [14]. After 12 days of dox
induction, we recovered GFP+ and GFP2 iPSC-like colonies
at a ratio similar to that in the starting MEF population.
Moreover, GFP+ and GFP2 colonies could be maintained in
the absence of dox, indicating autonomous self-renewal
capacity without the continuous need for exogenous factor
expression (Figures 1A and 1B).
To determine whether iPSC-like colonies exhibit molecular
hallmarks of authentic iPSCs, we evaluated endogenous
pluripotency factor expression by immunostaining for OCT4,
SOX2, and NANOG (Figure 1C). We found that GFP+ colonies
expressed both OCT4 and SOX2 after dox withdrawal, indi-
cating that they had induced the endogenous pluripotency
network. GFP+ iPSC-like colonies also expressed PECAM1, a
marker of undifferentiated ESCs and iPSCs that is absent
frommoremature epiblast stemcells [15, 16] (Figure S1A avail-
able online). Importantly, NANOG expression was absent from
GFP+ colonies, whereas it was detectable in GFP2 (wild-type)
colonies, confirming that GFP expression indeed identifies
Nanog-deficient cells.
We next performed global gene expression analysis using
microarrays to determine how similar Nanog–/– iPSC-like
cells are to wild-type ESCs and iPSCs. Unsupervised clus-
tering of these samples revealed that Nanog–/– iPSCs are
highly similar to wild-type pluripotent cells but different
from the MEFs from which they were derived (Figure 1D).
Importantly, Nanog–/– MEFs clustered closely with indepen-
dently derived wild-type MEFs, indicating that the starting
cell populations for reprogramming were differentiated fibro-
blasts. Of note, the two Nanog–/– iPSC lines were more
similar to each other than they were to wild-type iPSC and
ESC lines, suggesting that the loss of Nanog results in mild
gene expression differences as has been reported previously
for Nanog–/– ESCs [10, 17]. Alternatively, differences in
genetic background between Nanog-deficient iPSCs and
wild-type ESCs and iPSCs might account for the differential
clustering [18]. The microarray data also confirmed that
Nanog–/– colonies express endogenous pluripotency genes
[5–9] at ESC-like levels including Oct4 (Pou5f1), Sox2, Klf4,
Sall4, Rex1 (Zfp42), and Dppa2 (Figure 1E). However, Esrrb
levels were reduced in Nanog–/– cells, which is in agreement
with the previous finding that Esrrb is a direct NANOG target
[17]. Lin28a and Utf1 levels were also reduced whereas
Nanog transcripts were undetectable in Nanog-deficient
iPSC-like cells. Bisulfite sequencing of the Nanog and Oct4
promoter regions showed extensive demethylation relative
to fibroblasts (Figure S1B), indicating that both loci are in
an accessible ESC-like epigenetic state. Together, these
results show that Nanog–/– MEFs can generate iPSC-like
Figure 1. Nanog–/– MEFs Can Be Reprogrammed
to iPSCs
(A) Experimental outline.
(B) Fluorescent image of Nanog–/– iPSCs main-
tained in 2i/LIF and neomycin (left, phase;
right, GFP).
(C) Immunofluorescence for OCT4, SOX2, and
NANOG on a mixed culture of GFP+ Nanog–/–
(KO) and GFP2 wild-type (WT) iPSCs.
(D) Global gene expression microarrays were
performed on RNA purified from the indicated
cell lines. Shown is the hierarchical clustering of
one WT ESC line, two WT iPSC lines, two
Nanog–/– iPSC lines, and WT and KO MEFs
(left), as well as scatter plot analyses comparing
the indicated populations (right).
(E) Expression data from the microarray for
selected pluripotency markers. Results are
shown normalized to WT ESC expression levels.
(F) Fluorescent images of E13.5 chimeras gener-
ated from injecting Nanog–/– iPSCs into wild-type
blastocysts (top, phase; bottom, GFP).
(G) Adult chimeric mice generated from Nanog–/–
iPSCs. Agouti coat color indicates chimerism
derived from the Nanog–/– donor cells, whereas
the black coat color indicates chimerism derived
from the recipient wild-type blastocyst cells.
See also Figure S1.
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bona fide iPSCs.
Nanog-Deficient iPSCs Give Rise to Teratomas and
Chimeras
At a functional level, iPSCs are defined by the capacity to self-
renew indefinitely in culture and pluripotency, the ability to give
rise to cell types of all three germ layers. Indeed, we were able
to maintain GFP+ iPSC-like cells in culture for multiple pas-
sages, regardless of culture conditions (ESC media supple-
mented with serum/LIF or serum-free 2i/LIF conditions) [19].
However, we noticed thatGFP+ cells had a propensity to differ-
entiate in culture, in accord with the reported phenotype of
Nanog–/– ESCs [10]. Of note, exposure of Nanog-deficient
iPSC-like cells to neomycin eliminated differentiated cells
and maintained phenotypically undifferentiated colonies(Figure 1B). To assess the differentia-
tion potential of Nanog–/– colonies, we
sorted GFP+ and GFP2 cells and in-
jected them separately into the flanks
of SCID mice. Both Nanog–/– and wild-
type cells gave rise towell-differentiated
teratomas, characterized by ecto-
dermal, endodermal, and mesodermal
derivatives, hence meeting one criteria
of pluripotency (Figure S1C).
A more stringent assay of pluripo-
tency is the ability of cells to contribute
to chimeras. We therefore injected
GFP+ Nanog–/– iPSC-like cells into E3.5
wild-type blastocysts, transplanted
them into the uterus of pseudopregnant
recipient females, and isolated resultant
fetuses atmidgestation.We obtained 14
viable E13.5 embryos from 53 implanted
blastocyts, of which 11 embryos had
variable contributions of GFP chimerism(Figure 1F). These embryos gave rise to GFP+ MEFs and GFP+
neural progenitor cells (NPCs) in vitro, corroborating that the
reprogrammed Nanog–/– cells had the potential to differentiate
into mesodermal and a defined ectodermal lineage, respec-
tively (Figure S1D). Additionally, immunohistochemistry of the
chimeric embryos for GFP demonstrated that the Nanog–/–
iPSC-like cells contributed to all three germ layers, including
the neuroectoderm of the brain, the endoderm-derived lining
of the gastrointestinal tract, and the mesoderm-derived
smoothmuscle layers of the gastrointestinal tract (Figure S1E).
We also found thatNanog–/– iPSC-like cells could contribute to
adult chimeric mice (Figure 1G), indicating that these progeni-
tors have the capacity to fully mature and contribute to adult
tissues. Collectively, these data demonstrate that the reprog-
rammed Nanog–/– cells are pluripotent iPSCs and are thus
functionally equivalent to Nanog–/– ESCs.
Figure 2. Ascorbic Acid Rescues the Nanog–/– Reprogramming Defect
(A) Nanog–/– MEFs were reprogrammed in serum/LIF with or without 2i and/
or AA as indicated. The resulting dox-independent iPSC colonies were
stained for alkaline phosphatase and counted. Results are shown as the
average percent reprogramming efficiency (iPSC colonies / starting number
of MEFs) based on four separate replicates 61 SD (left). Alkaline phospha-
tase staining of a representative plate is shown (right).
(B) MEFs (d0 Thy1+) or reprogramming intermediates (Thy12SSEA-1+)
were analyzed by flow cytometry for average percent GFP positivity 61
SD based on three to five replicates per time point.
(C) Reprogramming intermediates at the indicated times after dox induction
were analyzed by flow cytometry for Thy1, SSEA-1, and EpCAM (left) or
PECAM1 (right) expression. Plots are gated on Thy12SSEA-1+ cells (gray
shaded histogram, isotype-matched control antibody). Statistical signifi-
cance was determined by the Student’s t test (*p < 0.05; **p < 0.005).
See also Figure S2.
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of Nanog-Deficient Cells
Our results differ from a previous report, which documented
that Nanog is required for the generation of iPSCs [12]. A
number of experimental differences between our studies
may account for this discrepancy, including the selection of
starting cell type (NPCs versus the MEFs used here) and
iPSC derivation conditions. We found that Nanog–/– NPCs
derived from our chimeras could be reprogrammed into iPSCs
(data not shown), thus excluding the possibility that the use of
distinct cell types can explain the observed difference in
reprogramming potential. We therefore focused on the
possible effect of environmental cues on the reprogramming
potential of Nanog–/– cells (Figure 1A). Our reprogramming
media contained serum/LIF and ascorbic acid (AA) [20],
whereas the previous study initiated reprogramming experi-
ments in serum/LIF and then switched to 2i (two inhibitors; a
combination of GSK3b and MEK inhibitors)/LIF media [19].
Given these differences in reprogramming conditions, we
tested the individual effects of 2i andAAon the reprogramming
ability of Nanog–/– MEFs. Whereas the addition of 2i had only aminor effect on reprogramming efficiency, the removal of
AA significantly impaired the reprogramming potential of
Nanog–/– MEFs (Figure 2A). Together, these data suggest
that a lack of AA impedes the formation of iPSCs in serum/
LIF or serum/2i/LIF conditions and thus may account for the
previous failure to derive or detect Nanog-deficient iPSCs.
To gain mechanistic insights into the effect Nanog and AA
may have on reprogramming, we analyzed nascent iPSCs
based on surface markers that distinguish refractory (THY1+
SSEA-12) from progressing (THY12SSEA-1+) intermediates
[21–23]. Nanog deficiency appears to impact only mid-to-late
stages of reprogramming, as suggested by the relative
decrease of GFP+SSEA1+ intermediates by day 12 of reprog-
ramming in the absence of AA (Figure 2B). This finding is
consistent with the late activation of a Nanog-GFP reporter
during iPSC formation (Figure S2). Remarkably, exposure of
reprogramming cultures to AA entirely rescued this defect.
We next analyzed Nanog–/– reprogramming intermediates
for EPCAM and PECAM1 surface expression, which identify
the mid and late stages of reprogramming, respectively [21],
in order to delineate the precise step at which Nanog is
required (Figure 2C). In wild-type cells undergoing reprogram-
ming, EPCAM expression becomes detectable by day 6 of
OKSM expression and correlates with Nanog transcription.
Furthermore, the Epcam locus is bound by NANOG in ESCs,
suggesting a direct regulation of Epcam expression by
NANOG [21]. In contrast, PECAM1 expression is activated
late (day 9) in iPSC formation and coincides with Oct4 expres-
sion in wild-type cells. Surprisingly, EPCAM was expressed
normally inNanog–/– nascent iPSC cultures at day 6, indicating
that Nanog deficiency affects neither Epcam transcription nor
the mid stages of reprogramming. However, PECAM1 expres-
sion was absent from Nanog–/– intermediates at day 9 under
serum/LIF conditions. Importantly, continuous AA treatment
of Nanog–/– reprogramming cultures restored normal PECAM
expression at day 9. Whereas nearly all SSEA1+ cells had
turned on PECAM1 by day 12 of reprogramming in the
presence of AA, a minor population of PECAM1+ cells was
also detectable in the absence of AA, and these cultures
gave rise to rare iPSC-like cells. Altogether, these results are
consistent with the interpretation that Nanog is important dur-
ing late stages of reprogramming by facilitating the transition
to a stable self-sustaining pluripotency network (as indicated
by PECAM1 and hence Oct4 positivity). AA treatment facili-
tates this step but may not be absolutely required (Figure 2A).
Discussion
Our results show that Nanog is dispensable for iPSC induction
when directly reprogramming fibroblasts in serum/LIF in the
presence of AA. More generally, these results demonstrate
that subtle changes in culture conditions can profoundly influ-
ence the genetic requirements for induced pluripotency. We
surmise that the previous failure to derive iPSCs from
Nanog-deficient cells was due to alternative derivation condi-
tions, which involved the generation of a pre-iPSC intermedi-
ate and a switch from serum/LIF to 2i/LIF in the absence of
AA [12]. A recent study demonstrated that overexpression of
NANOG’s target ESRRB can substitute for NANOG during
induced pluripotency, suggesting functional redundancy
[17]. However, iPSC formation in that study also required addi-
tion of the global demethylating agent 5-aza-cytidine, whereas
we obtained iPSC colonies in conventional culture conditions
without the need for 5-aza-cytidine or ectopic expression of
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from Nanog null cells, it will be interesting to further dissect
the mechanism by which AA compensates for the lack of
Nanog expression. One attractive model is that AA acts as a
cofactor for TET enzymes, which have been shown to bind
to NANOG and induce demethylation of pluripotency targets
including Esrrb and Oct4, thus promoting induced pluripo-
tency [24, 25].
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